Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors Use among Heart Failure Patients and the Role of Pharmacists in Early Initiation of Therapy

Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors Use among Heart Failure Patients and the Role of Pharmacists in Early Initiation of Therapy

Heart failure (HF) is a growing major public health and economic concern in the United States and worldwide. Heart failure mortality rates can be as high as 75% despite advances in therapies. HF is expected to be the fastest growing among all cardiovascular diseases, with HF-associated direct medica...

Full description

Bibliographic Details
Main Authors: Mohammed Aldhaeefi, Brandon Beers, Jenny Shah, Saba Saeidi Rizi, Dhakrit Rungkitwattanakul, Oliver Nimoh, Victoria Frimpong, Jackie Gonzalez, Sanaa Belrhiti, Fatima Urooj, Deborah Williams
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Pharmacy
Subjects:
heart failure
SGL-2 inhibitors
pharmacists
sodium-glucose cotransporter-2 inhibitors
Online Access:https://www.mdpi.com/2226-4787/11/2/58

Internet

https://www.mdpi.com/2226-4787/11/2/58

Similar Items